NCT04774289View on ClinicalTrials.gov

Incidence of Malignant Peripheral Nerve Sheath Tumor (MPNST) Development in Participants With Neurofibromatosis Type 1 (NF1) Receiving and Not Receiving Medical Therapies Directed at Plexiform Neurofibromas (PN)

CompletedOBSERVATIONAL

Enrollment

296

Participants

Timeline

Start Date

February 24, 2021

Primary Completion Date

March 1, 2022

Study Completion Date

December 8, 2022

Conditions

Neurofibromatosis 1Peripheral Nerve Neoplasms, Malignant

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT04774289 - Incidence of Malignant Peripheral Nerve Sheath Tumor (MPNST) Development in Participants With Neurofibromatosis Type 1 (NF1) Receiving and Not Receiving Medical Therapies Directed at Plexiform Neurofibromas (PN) | Biotech Hunter | Biotech Hunter